Keith Hautala

By

College: Pharmacy

UK Pharmacy Professor Develops New Tool to Prevent Heroin Deaths

Published: Aug 7, 2014

 

Video by UK Research Media

 

 

LEXINGTON, Ky. (Aug. 7, 2014) — A new, lifesaving product aimed at reducing the death toll from heroin abuse — developed by a professor at the University of Kentucky College of Pharmacy — is in its final round of clinical trials and has received Fast Track designation by the Food and Drug Administration.

 

The product, a nasal spray application of the anti-opioid drug naloxone, was developed by Daniel Wermeling, UK professor of pharmacy practice and science, through his startup company AntiOp Inc.

 

Naloxone is the standard treatment for suspected opioid overdose, already in use by emergency rooms and emergency medical technicians across the country. Opioids are the class of pain-killing drugs that are related to morphine, including prescription drugs such as hydrocodone and oxycodone, as well as illegal drugs such as heroin.

 

Currently, naloxone is administered by injection. The nasal spray eliminates the need for needles, with a ready-to-use, single-use delivery device inserted into the nose of an overdose victim. The product delivers a consistent dose, absorbed across the nasal membranes even if the patient is not breathing.

 

"The goal is to make the medication available to patients at high risk of opioid overdose, and to caregivers, including family members, who may lack specialized medical training," Wermeling said. "The treatment could be given in anticipation of EMS arrival, advancing the continuum of care and ultimately saving lives."

 

Nationwide, deaths from opioid overdose are on the rise, according to data from the Centers for Disease Control and Prevention. Kentucky, long troubled by widespread abuse of prescription opioids, has seen a dramatic rise in deaths from heroin overdose in recent years. In autopsies from 2013, the state medical examiner attributed 230 deaths to heroin overdose, an increase of more than 60 percent from the previous year.

 

UK President Eli Capilouto congratulated Wermeling on his success with AntiOp, saying that it reflects the core values of the university.

 

"Too many Kentucky families have experienced the tragedy of seeing a loved one's life cut short by a drug overdose," Capilouto said. "The epidemic of opioid abuse in our state presents an enormous and urgent challenge, not only for health care providers and law enforcement, but also for us here at the University of Kentucky. Dr. Wermeling's project is putting a powerful new tool into the hands of those on the front line of the fight against heroin, both here in Kentucky and beyond. This type of innovation embodies the three main components of the university's mission — education, research and, above all, service."

 

UK College of Pharmacy Dean Timothy S. Tracy said Wermeling's work also provides an illustration of "bench-to-bedside" research in action.

"Dr. Wermeling’s project is a great example of how UK College of Pharmacy faculty are working each and every day to create healthier Kentucky communities," Tracy said. "Dr. Wermeling and his collaborative team of research colleagues saw a problem facing families in Kentucky and across the nation and developed an innovative solution. That type of translational approach is important to our college, this university, and, of course, the future of our Commonwealth."

 

Wermeling's research was supported by a three-year, $3 million grant from the National Institutes of Health through the National Institute on Drug Abuse with additional funding from the Kentucky Science and Technology Corporation. In May, AntiOp partnered with Reckitt Benckiser Pharmaceuticals to accelerate production and worldwide marketing of intranasal naloxone.

 

The Fast Track program of the FDA is designed to expedite the development and review of new drugs that are intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs. Fast Track-designated drugs ordinarily qualify for priority review, thereby expediting the FDA review process.

 

"As an educator, pharmacist, researcher and entrepreneur, being able to work on this naloxone project has been a dream come true," Wermeling said. "I often tell my students and colleagues that this project has allowed me to use all of the skills I have learned over the years. It has been the ultimate problem-solving project, requiring me to utilize my pharmacological skills, my drug delivery knowledge, my business and marketing skills — all at the same time.

 

"At the end of the day, however, this project has always been about people. It has always been about utilizing the knowledge and skills that we have to improve patient care."

 

MEDIA CONTACT: Keith Hautala, 859-323-2396; keith.hautala@uky.edu

wermeling.jpg
January
 
 
 
 
1
 
Thu
2
 
Fri
3
 
Sat
4
 
Sun
5
 
Mon
6
 
Tue
7
 
Wed
8
 
Thu
9
 
Fri
10
 
Sat
11
 
Sun
12
 
Mon
13
Job Club: Job Search Strategies for the New Year: A 15 Day Action Plan
Tue
14
Bicycle Trivia
LNFS Presents: Hercules
Wildcat Wellness: Meditation
Wed
15
LNFS Presents: Dazed and Confused
LNFS Presents: Boyhood
MLK "I Have A Dream" Silent March, Vigil & Program
Thu
16
MLK Multicutural Org Fair
Fri
17
 
Sat
18
 
Sun
19
 
Mon
20
 
Tue
21
LNFS Presents: Mission Impossible 3
Wildcat Wellness: Meditation
Caregiver Support Group
Wed
22
LNFS Presents: Big Hero 6
LNFS Presents: Together With You (He ni zai yi ki)
Thu
23
LNFS Presents: Five Broken Cameras
LNFS Presents: Scott Pilgrim vs. the World
National Student Exchange (NSE) Info Session
Cultural Coffee Hour
Fri
24
Pershing Rifles Drill Meet
Welcome Back Students Swing Dance!
Sat
25
 
Sun
26
Career & Major Exploration Session @ 11 a.m.
Career & Major Exploration Session @ Noon
Career & Major Exploration Session @ 2 p.m.
Mon
27
Pinterest Party #1
Job Club: Using Networking to Find and Land a Hidden Job
Career & Major Exploration Session @ 1 p.m.
Career & Major Exploration Session @ 2 p.m.
Career & Major Exploration Session @ 3 p.m.
Tue
28
LNFS Presents: There Will Be Blood
Wildcat Wellness: Meditation
National Student Exchange (NSE) Info Session
Chapel Talk: Why The Church Should Support Marriage Equality
Wed
29
LNFS Presents: Mulholland Drive
LNFS Presents: Fury
Tattoo Exhibit
CatWatch Party #1
Thu
30
LNFS Presents: Clerks
LNFS Presents: Friday
Cultural Coffee Hour
Faculty Media Depot Opening Reception
Fri
31
 
Sat

Fri, 01/30/2015

Repeats every week every Friday until Fri May 01 2015 .
Fri, 01/30/2015

Mon, 02/02/2015

Reset Page